Skip to content

35,125 Entries
34 Added in Past 24 Hours

International Security Advisory Board Releases Three Reports — “Report on Biotechnology in the PRC’s Military-Civil Fusion Strategy,” “Report on Multilateral Disarmament Structures,” and “The Limits of Influence: U.S. Security Cooperation in the Age of Strategic Competition.”

Excerpt:  “Like the United States and many other nations, the People’s Republic of China (PRC) has identified biotechnology as a driver of economic growth and innovations for health, food, environmental, and energy security as well as sustainable manufacturing. However, the PRC strategic focus on developing its biotechnology sector goes far beyond the traditional industrial policies employed by other global biotech leaders. Under a series of national plans and policies that have been building for decades, the PRC has designated biotechnology a strategic emerging industry, calling for a whole-of-nation, top-down effort using expertise, financing, subsidies, and diplomatic support to mobilize biotechnology innovation as an element of “comprehensive national power.” (footnote omitted)